ALFA Finder| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 6541.2 | 7074.5 | 6729.7 |
| Other income | 148.2 | 206.3 | 289.5 |
| Total income | 6689.4 | 7280.8 | 7019.1 |
| Profit before exceptional items & tax | 707.1 | 1169.0 | 1504.3 |
| Exceptional items | 0.0 | -275.9 | 0.0 |
| Profit before tax | 707.1 | 893.1 | 1504.3 |
| Net profit | 542.5 | 674.2 | 1214.1 |
| Operating margin | 10.6% | 12.3% | 21.4% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -55.30% |
|---|---|
| Net profit, quarter on quarter | -19.50% |
| Revenue, year on year | -2.80% |
BSE results filing, NSE: CIPLA. Figures extracted from the filing.
Cipla Ltd: key numbers
- Share price
- ₹1,391.80
- Market cap
- ₹1,12,442 Cr
- Revenue (annual)
- ₹28,163 Cr
- Net profit (annual)
- ₹3,879 Cr
- P/E (TTM)
- 38.8×Sector 43.7×
- Promoter holding
- 29.21%+0.00% QoQ
- FII holding
- 20.24%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Cipla Ltd
All →Cipla Management Change
Cipla Limited has appointed Mr. Vikram Janakiraman as the Global Chief Technical Operating Officer. He joins as Senior Management Personnel with effect from 7th December, 2026.
Cipla Earnings Call Transcript: Key Takeaways
Cipla delivered record India revenue and margin expansion, masking high-stakes US product approval dependencies.
- Call
- Guides 20% growth
Cipla Employee Stock Options
Cipla granted 8,679 stock options and 27,140 ESARs to employees under its 2013 and 2021 schemes. Exercise price is INR 2 per option with graded vesting.
Cipla Management Change
Cipla's Board appointed Ms. Rashmi Joshi as additional Independent Director for 5 years. This strengthens the board's governance and financial oversight capabilities.
Cipla Investor Presentation: Key Takeaways
Q2FY27 consolidated revenue INR 7,404 Cr (-2.4% YoY), EBITDA INR 1,388 Cr (18.7% margin), PAT INR 878 Cr (11.9%). Record quarterly India revenue; licensing deals in oncology biosimilars and ADCs.
Cipla Results Update
Cipla reported Q2FY27 consolidated revenue of ₹7,404 Cr and PAT of ₹878 Cr. EBITDA margin expanded 200 bps QoQ to 18.7%, with One-India growing 12% YoY.